ADRB2 and cardiac arrhythmia: Inhibition of CaMKII has been shown to suppress isoproterenol-induced arrhythmias in vivo [86,87], as well as prevent the increased effects of stress-induced β-AR stimulation on cardiac contractility and Ca2+-handling [88].